AzTrials
AzTrials

Developmental Coordination DisorderRVA_DCDNCT04126395

An Explorative RVA of the Motor Development of Children With DCD <2y

An observational study of Developmental Coordination Disorder and Autism Spectrum Disorder, run by University Ghent at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares motor development in three groups of infants (controls, DCD, DCD+ASD) before the age of 2 years using retrospective video analysis of infants in home video contexts. Read more about this study

Who is it for?
Ages 6 to 12 yearsHealthy volunteers can take part
What is being tested?
Movement Assessment Battery for Children 2(M-ABC-2), Developmental Coordination Disorder - Questionnaire (DCD-Q) and Social Responsiveness Scale 2 (SRS-2)
How many people
49 participants
Where
2 sitesin 2 countries
Study dates
14 Sep 2020to 25 Jul 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Community sample

Who may be able to join

  • Availability of video material of the child before the age of 2.
  • No indication of DCD (as measured by M-ABC-2 Pc>16 and DCD-Q)
  • No indication of ASD (as measured by SRS-2 T-score ≤60 )
  • Availability of video material of the child before the age of 2.
  • Formal diagnosis of DCD provided by multidisciplinary team in Flanders
  • Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q)
Show all 10Show fewer
  • Availability of video material of the child before the age of 2.
  • Formal diagnosis of DCD and ASD provided by multidisciplinary team in Flanders
  • Indication of DCD (as measured by M-ABC-2 Pc≤16 and DCD-Q)
  • Indication of ASD (as measured by SRS-2 T-score >60 )

Who cannot join

  • Medical diagnosis possibly influencing motor development (DCD, ASD, ADHD, CP, ect)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)
  • DCD GROUP:
  • Other medical diagnosis possibly influencing motor development (ASD, ADHD, CP, ect)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
Show all 11Show fewer
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)
  • DCD+ASD GROUP:
  • Other medical diagnosis possibly influencing motor development (ADHD, CP, ect.)
  • Severe ilnesses in the early Developmental period (0-2y) which may have influenced the development (f.e. CVA, cancer, severe traumas,...)
  • Prolonged admission to the hospital (≥ 3 weeks) in the early Developmental period (0-2y)

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Belgium1 site
  • Ghent University

    Ghent, 9000

Other trials in Belgium

Canada1 site
  • UBC

    Vancouver

Other trials in Canada

About this study

Official title: An Explorative Retrospective Video-analysis of the Motor Development of Children With Developmental Coordination Disorder Before the Age of Two

This study compares motor development in three groups of infants (controls, DCD, DCD+ASD) before the age of 2 years using retrospective video analysis of infants in home video contexts.

Being tested
Movement Assessment Battery for Children 2(M-ABC-2), Developmental Coordination Disorder - Questionnaire (DCD-Q), Social Responsiveness Scale 2 (SRS-2), Retrospective Video Analysis
Keywords
motor development, baby, infant, motor milestones, crawling, independent walking
Medical subject headings
Motor Skills Disorders, Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Movement Assessment Battery for Children 2(M-ABC-2)Diagnostic test

    The M-ABC-2 is a motor performance test for children aged 3 trough 16 years of age. We will use Dutch-Flemish norms.

  • Developmental Coordination Disorder - Questionnaire (DCD-Q)Diagnostic test

    The DCD-Q is a brief parent questionnaire designed to screen for the presence of DCD in children aged 5 trough 15 years of age. We will use Dutch norms.

  • Social Responsiveness Scale 2 (SRS-2)Diagnostic test

    The SRS-2 is a parent questionnaire designed to identify social impairments associated with ASD in children 4 trough 18 years of age. We will used Dutch norms.

  • Retrospective Video AnalysisOther

    Retrospective video analysis will be used to explore motor development in children with DCD, DCD+ASD and controls.

Study groups in NCT04126395
Study groupRoleWhat they receive
ControlsThis groups consists of children now aged 6-12y: * Without a medical diagnosis possibly influencing motor development * Without motor problems (M-ABC-2 and DCD-Q) * Without social reponsiveness problems (SRS-2)
Receives: Diagnostic Test: Movement Assessment Battery for Children 2(M-ABC-2); Diagnostic Test: Developmental Coordination Disorder - Questionnaire (DCD-Q); Diagnostic Test: Social Responsiveness Scale 2 (SRS-2); Other: Retrospective Video Analysis
Developmental Coordination DisorderThis groups consists of children now aged 6-12y: * With a multidisciplinary diagnosis of DCD * With motor problems (M-ABC-2 and DCD-Q)
Receives: Diagnostic Test: Movement Assessment Battery for Children 2(M-ABC-2); Diagnostic Test: Developmental Coordination Disorder - Questionnaire (DCD-Q); Diagnostic Test: Social Responsiveness Scale 2 (SRS-2); Other: Retrospective Video Analysis
Developmental Coordination Disorder + Autism Spectrum DisorderThis groups consists of children now aged 6-12y: * With a multidisciplinary diagnosis of DCD * With motor problems (M-ABC-2 and DCD-Q) * With social responsiveness problems (SRS-2)
Receives: Diagnostic Test: Movement Assessment Battery for Children 2(M-ABC-2); Diagnostic Test: Developmental Coordination Disorder - Questionnaire (DCD-Q); Diagnostic Test: Social Responsiveness Scale 2 (SRS-2); Other: Retrospective Video Analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Observable Movement Quality Scale

    The OMQ is a standardized 15-item observational scale to asses the movement quality. A maximum of two 5-minute compilations are assembled per child per age-category (6-12 months, 12-18 monhts, 18-24 months)

    Measured: 0-2years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2019
  2. Study start14 Sep 2020
  3. Primary completion25 Jul 2023
  4. Study completion25 Jul 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04126395
Sponsor's protocol ID
BC-05716
Acronym
RVA_DCD
Status last verified
Feb 2024
First submitted
11 Oct 2019
Last updated
22 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Developmental Coordination Disorder and Autism Spectrum Disorder, run by University Ghent at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium, Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Observable Movement Quality Scale (time frame: 0-2years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2024; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in